Background This study was undertaken to expand the understanding of ultrasound-guided compression repair (UGCR) of postcatheterization femoral artery injuries.
Patients with pseudoaneurysms and AV fistulas were considered candidates for UGCR if reapplication of a firm compression bandage for 24 hours failed to cure the lesion and if contraindications could be ruled out; the latter included infection, overlying skin ischemia, impending compartment syndrome, and severe pain in the groin.
The following procedure was used throughout the entire course of our study without any subsequent modifications: First, an attempt was made to detect the tract or neck leading from the arterial lumen to the lesion. The transducer was then positioned directly above the tract, and pressure was increased gradually until flow in the tract was eliminated. If the tract could not be localized, extraluminal flow was stopped by direct compression of the pseudoaneurysm itself. Frequently the minimum force required to arrest the flow in the tract and within the injury itself also occluded the femoral artery. This was not considered to be a contraindication for UGCR. Analgesic or sedative medication was not used routinely during the procedure; instead, an attempt was made to distract the patients and to make them feel comfortable by verbal reassurance. Approximately every 15 minutes, a change of operators was undertaken, without releasing the pressure or altering the position of the transducer. After 20 to 30 minutes, pressure was temporarily released every 10 to 15 minutes to check whether the lesion was cured; UGCR was stopped as soon as this was the case. The procedure was also terminated when success could not be obtained within 80 minutes. After the procedure, all patients immediately received a compression bandage and were put on bed rest for 24 hours. Follow-up color-flow examinations were performed 1 to 2 days after the procedure and before discharge of the patient.
In case UGCR failed, false aneurysms that were found to be stable in size were simply observed until they thrombosed spontaneously. In these patients, the compression bandage was also removed after 24 hours; this was followed by strict bed rest for 2 to 3 days and subsequent cautious mobilization. All but 11 lesions were identified at the first postprocedural duplex examination 1 to 6 days after the intervention (median, 2 days). In 9 patients, no lesion was apparent at the first follow-up scan 2 days after coronary stent implacement; subsequent check-ups 6 to 17 days (median, 10 days) after the procedure revealed a pseudoaneurysm. Another two pseudoaneurysms were detected during a follow-up examination in the outpatient department 2 and 4 weeks after catheterization of the femoral artery.
All procedures were completed as planned. Upon beginning the procedure, patients frequently complained of discomfort. This diminished greatly, however, once the operator had taken a definitive position and the patient had become accustomed to compression. Occasionally, mild transitory vagal reactions ocurred, which did not require any specific treatment. No other adverse effects were observed.
False Aneurysms
In patients without anticoagulants, UGCR was performed either on the day the lesion was detected (10 cases) or after a second compression bandage failed to cure the injury (17 cases), resulting in an interval of 0 to 5 days (mean, 1.5 days; median, 1 day) after the diagnosis was made. Patients with coronary stents are maintained on high-intensity oral anticoagulant therapy and aspirin for a period of 6 to 12 weeks at our institution. UGCR was performed in all but one of these patients after stabilization of the INR, usually 5 to 10 days after stent implacement, without interruption of the administration of oral anticoagulants and aspirin; in one case, UGCR was postponed until oral anticoagulants had been stopped.
Ten of the 27 who were not on oral anticoagulants were taking aspirin (100 or 300 mg/d). Permanent cure was obtained in 25 of these 27 patients, resulting in a cure rate of 93% (Table) 14 patients was between 2.5 and 6.0 (mean, 3.9; median, 4.5) at the time of compression repair. Temporary success was achieved in 6 additional patients (INR, 3.5 to 6; mean, 4.7; median, 5.0), but the pseudoaneurysms recurred overnight and could not be cured permanently despite a second UGCR attempt. Compression repair failed in 6 patients with an INR of 3.5 to 6.0 (mean, 4.9; median, 5.0). Thus, no significant correlation could be found between the INR at the time of UGCR and therapeutic success.
Neither the size of the pseudoaneurysm (diameter, 5 to 60 mm; mean, 24 mm; median, 21 mm) nor the age of the lesion (0 to 29 days; mean, 9.4 days; median, 6 days) could be discerned as a discriminant predictor of success (Table) . The detection of the aneurysmatic tract was also of no predictive value in patients without anticoagulants. In patients on oral anticoagulants, however, there was a positive correlation between the length of the aneurysmatic tract and the success of UGCR: In 24 patients on oral anticoagulants, a communicating channel between the extraluminal cavity and the femoral artery could be detected by duplex scanning; in 2 pseudoaneurysms, the extraluminal cavity was located so close to the femoral artery that no communicating channel could be detected. UGCR was successfully performed on 1 week after anticoagulant therapy was ended, 2 were closed by percutaneous implantation of collagen plugs, and 2 were treated surgically. One patient died of renal failure (6 days after the last follow-up duplex scan), and another patient was discharged with arrangements for clinical follow-up of the pseudoaneurysm (Fig 1) . AV Fistulas UGCR was also performed on 9 patients with an AV fistula. None of them were on anticoagulants. In 3 cases, the lesion could be repaired by UGCR (compression time, 45 and 60 minutes) (Fig 2) . All 3 were characterized by a long channel that was easy to depict and to compress by ultrasound guidance. In the other 6 
Discussion
Because of altered anticoagulation regimes and larger-size percutaneous instruments, the incidence of local complications following percutaneous femoral catheterization has increased in the past few years. Recent studies have shown a false aneurysm rate of 1.6% after cardiac catheterization and 0.7% to 6.3% after percutaneous transluminal coronary angioplasty.15-20 In addition, it has been suggested that pseudoaneurysms and AV fistulas may be detected more frequently when patients are examined routinely with color-flow duplex ultrasound after invasive procedures.3,11""2'21
The common treatment for false aneurysms has been surgical repair,18'2223 since they may lead to infection, compression neuropathy, rupture, progressive enlargement, and blood loss, while large AV fistulas may cause congestive heart failure and progressive dilatation of the veins draining the lesion. In 1986, Cope and Zeit24 described the coagulation of pseudoaneurysms by direct percutaneous thrombin injection. This method, however, requires the elimination of blood flow into the extraluminal cavity. In their original report, Fellmeth and Roberts' reported a series of 29 postcatheterization injuries (27 pseudoaneurysms and 2 AV fistulas) that had been treated by this method; 26 false aneurysms and 1 AV fistula had been successfully repaired by UGCR. Subsequent reports on this method confirmed the advan- While our study further corroborates these results with a success rate of 93% in patients without anticoagulation, our criteria for indications and performance of UGCR differed in several aspects from those of the other authors mentioned above, major issues being the use of anticoagulants, concomitant compression of the femoral artery, and the age of the lesion.
There have been sporadic previous reports about successful UGCR in patients on oral anticoagulant therapy, 2225 but anticoagulants were either withheld before UGCR or given at moderate doses only, with a prothrombin ratio ranging from 1.3 to 1.8. Of our patients, 26 were on simultaneous aspirin therapy and intensive oral anticoagulation therapy, with an INR ranging from 2.5 to 6.0. Neither aspirin nor phenprocoumon was withheld for UGCR; 14 of 26 patients on oral anticoagulants (54%) were successfully treated by this method (Table) . Although the success rate of UGCR is lower in patients who are on oral anticoagulants, we believe it is good enough to justify an attempt with UGCR also in patients on anticoagulants, especially if one considers the risks of alternative procedures, such as surgery or awaiting spontaneous thrombosis.
In 45 of our patients, the vascular lesion could be compressed completely only with simultaneous temporary occlusion of the underlying femoral artery and vein. This has generally been regarded to be a contraindication for continuing the procedure 4"1 after the report of a case of subacute occlusion of the femoral artery under these conditions (Fellmeth and Roberts').
We observed no such complication in any of the 45 patients in whom UGCR resulted in complete compression of the femoral artery and vein; therefore, we do not consider the need for simultaneous compression of the large femoral vessels to be a contraindication to UGCR.
"Longstanding' lesions have been reported to be unsuitable for UGCR..24.D.9.2U2 We attempted UGCR in 3 patients with pseudoaneurysms that were even older than 4 weeks (29, 32, and 59 days after catheterization of the femoral artery). All of them could be successfully repaired (Table) . Therefore, "chronic lesions should not be excluded from a UGCR attempt.
While the intensity of anticoagulation (INR, 2.5 to 6) was not a prognostic factor for the success of the procedure in patients who were on anticoagulants, the length of the communicating tract proved to be predictive (Fig 3) . False aneurysms with an aneurysmatic tract > 10 mm long could be permanently occluded by UGCR in 11 cases, whereas only 3 lesions with a communicating channel < 10 mm long were successfully treated by this method (Table). AV fistulas have rarely been treated with UGCR '20 and until now with little success. We were successful in 3 of 9 cases; all 3 were characterized by a long communicating channel between the femoral artery and the vein, whereas no communicating tract could be found in the remaining patients.
In conclusion, we consider UGCR to be the technique of first choice for the treatment of postcatheterization femoral artery injuries, even in patients on anticoagulants. Our results additionally suggest that lesions can be treated by this method irrespective of size and age, even when the femoral artery has to be compressed simultaneously.
